**Core Concept**
The question is testing the student's knowledge of antifungal agents that target the ergosterol biosynthesis pathway. Ergosterol is a critical component of fungal cell membranes, and inhibiting its biosynthesis disrupts the cell membrane's integrity, ultimately leading to fungal cell death.

**Why the Correct Answer is Right**
The correct answer, Fluconazole, is an azole antifungal agent that inhibits the enzyme lanosterol 14α-demethylase (CYP51). This enzyme is essential for the conversion of lanosterol to ergosterol in the ergosterol biosynthesis pathway. By inhibiting CYP51, Fluconazole reduces ergosterol levels, leading to cell membrane disruption and ultimately fungal cell death.

**Why Each Wrong Option is Incorrect**
* **Option A:** Amphotericin B is a polyene antifungal agent that binds to ergosterol in the fungal cell membrane, but it does not inhibit ergosterol biosynthesis. Instead, it forms pores in the cell membrane, leading to cell lysis.
* **Option B:** Griseofulvin is an antifungal agent that inhibits fungal cell division by binding to microtubules, but it does not affect ergosterol biosynthesis.
* **Option C:** Itraconazole is another azole antifungal agent, but it is not the correct answer because the question is asking for the agent that specifically inhibits ergosterol biosynthesis, and Fluconazole is more commonly associated with this mechanism.

**Clinical Pearl / High-Yield Fact**
Azole antifungal agents, such as Fluconazole, are commonly used to treat fungal infections, including candidiasis and aspergillosis. It's essential to remember that these agents can interact with other medications, such as warfarin, and should be used with caution in patients with liver disease.

**Correct Answer:** C. Fluconazole